MBX vs T · $1.98B cap vs P/E 7.4, rev $125.65B
MBX Biosciences, Inc. Common Stock (MBX) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
MBX does not have a complete income-statement cache yet.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
MBX currently screens at market cap $1.98B. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the MBX and T stock pages for the full models.
Not investment advice.